Text
Analisis Hitung Limfosit Plasma Biru dan Monosit untuk Membantu Menentukan Derajat Berat-Ringannya Infeksi Virus Dengue di Rumah Sakit Advent Bandar Lampung
Abstract: Count Analysis blue plasma lymphocjtesand monosit for Level infection Dengue virus in Advent Hospital Bandar Lampung. Diseases Dengue Hemorrhagic Fever (DHF) is an infectious disease caused by dengue virus and transmitted by the mosquito Aedes aegypti. DHF can. affect everyone and can lead to death. Tendency to be severe DHF appears from the report the case of some hospitals at the provincial level in Indonesia, between the years 1998-2004. The number ofDHF cases who suffered from shock is 18-45% of the number of cases treated, with the death of between 6- 51 %, or 4-10 times higher than those who do not suffer from shock. The study was conducted with a cross-sectional study design with observational analytic on patients aged 3-55 years who were clinically diagnosed as suffering from dengue infection and confirmed with dengue blot test positive at the Clinical Laboratory Advent Hospital Bandar Lampung, obtained as many as 220 objects of research. Analysis results show the percentage of plasma Iymphocytes can distinguish blue non¬dengue infection with primary dengue virus infection, the percentage of monocytes further differentiate non-dengue infection with secondary dengue virus infections, the percentage of monccytes was significantly different between primary infection with secondary infection with an overview serology and IgG-IgG +. There is inverse correlation between the number of monocyte and platelet counts at various serologic picture, there are also inverse correlation between the number of lymphocytes blue plasma and platelet counts in various serological picture, but the correlation of the number of monocytes better than the number of Iymphocyte plasma blue. Cut off point for the number of monocytes with dengue virus, severe thrombocytopenia was 16%, while •the cut-off point the number of lymphocytes, plasma blue for dengue virus infection with severe thrombocytopenia is 6%.
No other version available